Fate Therapeutics Inc. (FATE)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.84

1.10%

After-hours Dec 13, 2024, 06:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	63.53M	96.30M	55.85M	31.43M	10.68M	4.74M	4.11M	4.40M	2.43M	-	971.00K	2.67M	1.17M
Cost of Revenue	161.70M	13.76M	5.85M	125.62M	87.77M	56.02M	34.36M	26.45M	19.86M	16.43M	12.01M	12.00M	-
Gross Profit	-98.16M	82.54M	50.00M	-94.19M	-77.09M	-51.28M	-30.25M	-22.05M	-17.43M	-16.43M	-11.04M	-9.33M	1.17M
Operating Income	-190.51M	-308.39M	-216.99M	-128.09M	-100.73M	-67.09M	-42.13M	-31.96M	-27.78M	-24.90M	-17.68M	-13.56M	-13.29M
Interest Income	17.19M	5.84M	1.31M	2.40M	4.33M	2.19M	559.00K	138.00K	10.00K	2.00K	6.00K	1K	2.00K
Pretax Income	-160.93M	-281.72M	-212.15M	-173.39M	-98.15M	-66.60M	-42.95M	-33.46M	-29.99M	-25.88M	-20.89M	-14.24M	-13.43M
Net Income	-160.93M	-255.06M	-206.30M	-170.30M	-97.71M	-66.60M	-42.95M	-33.46M	-29.99M	-25.88M	-20.89M	-14.24M	-13.43M
Selling & General & Admin	79.45M	84.23M	57.32M	33.90M	23.64M	15.81M	11.87M	9.91M	10.35M	8.47M	6.64M	4.23M	4.61M
Research & Development	172.60M	320.45M	215.52M	125.62M	87.77M	56.02M	34.36M	26.45M	19.86M	16.43M	12.01M	12.00M	9.86M
Other Expenses	-	20.82M	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	254.04M	404.69M	272.84M	159.52M	111.41M	71.83M	46.23M	36.37M	30.21M	24.90M	18.65M	16.23M	14.46M
Interest Expense	-	5.84M	-	-	1.75M	1.70M	1.27M	1.64M	2.22M	549.00K	796.00K	487.00K	127.00K
Selling & Marketing Expenses	-2.00M	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	254.04M	404.69M	272.84M	159.52M	111.41M	71.83M	46.23M	36.37M	30.21M	24.90M	18.65M	16.23M	14.46M
Income Tax	-	-26.66M	-5.85M	-3.09M	-441.00K	2.19M	297.00K	-743.00K	-677.00K	53.00K	796.00K	487.00K	127.00K
Shares Outstanding (Basic)	98.41M	96.83M	94.75M	82.39M	68.19M	56.20M	41.98M	31.75M	25.48M	20.45M	5.90M	8.87M	8.87M
Shares Outstanding (Diluted)	98.41M	96.83M	94.75M	82.39M	68.19M	56.20M	41.98M	31.75M	25.48M	20.45M	5.90M	8.87M	8.87M
EPS (Basic)	-1.64	-2.63	-2.18	-2.07	-1.43	-1.19	-1.02	-1.05	-1.18	-1.27	-3.54	-1.61	-1.51
EPS (Diluted)	-1.64	-2.63	-2.18	-2.07	-1.43	-1.19	-1.02	-1.05	-1.18	-1.27	-3.54	-1.61	-1.51
EBITDA	-172.23M	-294.63M	-211.14M	-125.00M	-94.20M	-63.70M	-40.71M	-30.94M	-27.09M	-24.41M	-19.53M	-13.16M	-12.63M
Depreciation & Amortization	18.28M	13.76M	5.85M	3.09M	2.19M	1.20M	971.00K	881.00K	687.00K	496.00K	571.00K	590.00K	672.00K